Pharma: Trends an...
Follow
Find
18.5K views | +28 today
Rescooped by eMedToday from Digital marketing pharma
onto Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Is Pinterest Pharma’s Channel on the Visual Web?

Is Pinterest Pharma’s Channel on the Visual Web? | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Intouch solutions recommends creating a content strategy focused on better visual content instead of jumping onto the Pinterest platform bandwagon. (As one of the newest social media contenders – is #Pinterest right for #pharma co’s?

Via Olivier Delannoy
eMedToday's insight:

Clearly Pharma need to recognize that visual and video is where the action is.

 

"According to M Booth and Simply Measure, a social media analytics firm, we know that:

Videos on Facebook are shared 12 times more than links & text posts combined.Photos are liked 2 times more than text updates.100 million YouTube users are taking a social action, sharing, rating or commenting, on videos every week.Over 700 YouTube videos are shared on Twitter each minute.Pinterest users follow more brands than users on Facebook or Twitter"
more...
Rowan Norrie's curator insight, June 28, 2013 4:55 AM

Intersting article of the rise of the visual web and whether Pinterest might have a role for pharma and other life science companies.

Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Keep current on Pharma uses of mobile apps
Curated by eMedToday
Your new post is loading...
Scooped by eMedToday
Scoop.it!

For pharma, the era of multi-channel marketing, closed loop marketing, sales force effectiveness, and market access is over

For pharma, the era of multi-channel marketing, closed loop marketing, sales force effectiveness, and market access is over | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
The era in which pharma could expect to be able to speak of 'multi-channel marketing', 'closed loop marketing', 'sales force effectiveness', or 'market access' without being called out as to their ...
more...
No comment yet.
Rescooped by eMedToday from 9- PHARMA MULTI-CHANNEL MARKETING by PHARMAGEEK
Scoop.it!

Digital to Pass 25% of Global Media Spend for First Time

Digital to Pass 25% of Global Media Spend for First Time | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

Marketers will continue to pour more money into mobile and digital this year.


Via Angel Gonzalez, Lionel Reichardt / le Pharmageek
more...
Bettina Gifford's curator insight, July 10, 8:45 PM

choosing a direct channel like www.hcpmeetings.com.au in Australia maybe the answer? 

Scooped by eMedToday
Scoop.it!

Digital Marketing Budgets Increase, Reflecting ...

Digital Marketing Budgets Increase, Reflecting ... | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Digital marketing spend is rising. How does yours compare?
more...
No comment yet.
Rescooped by eMedToday from Hospitals: Trends in Branding and Marketing
Scoop.it!

The Doctor's Office of 2024: 4 Predictions for the Future

The Doctor's Office of 2024: 4 Predictions for the Future | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
What’s next on the horizon for doctors and patients? Medical experts predict the biggest changes likely to occur in primary care over the next decade.
[...]
- Doctors will rely on Wearbale tech for Real-time Insights..

Via Pharmacomptoir / Corinne Thuderoz, Celine Sportisse, eMedToday
more...
Laurent FLOURET's curator insight, July 9, 4:19 AM

Cannot wait for this one: "Waiting Rooms Will Be Phased Out"...

Rescooped by eMedToday from mHealth- Advances, Knowledge and Patient Engagement
Scoop.it!

What's pharma's impact on the mobile health app space? These 3 graphs offer some clues

What's pharma's impact on the mobile health app space? These 3 graphs offer some clues | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
A report highlighting the mobile health app landscape charts pharma companies that have produced the most apps, such as Bayer, Merck and Novartis.
more...
No comment yet.
Rescooped by eMedToday from #eHealthPromotion, #web2salute
Scoop.it!

FDA issues two draft guidances on Social Media

FDA issues two draft guidances on Social Media | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

Two NEW FDA DRAFT Guidances On the Use of Social Media and Online Promotions of Devices and Drugs

After five years in the making, the FDA is on a roll. Following the publication of the previous draft guidance on the use of social media for “post-marketing submissions for post marketing submissions of interactive promotional media“, the agency has published two new guidances of conduct of medical device and pharma companies in social media.

The first seems easier to understand and implement than the second.

Draft Guidance I: Correcting independent third-party misinformation about prescription drugs and medical devices

Imagine the following: You work as a sales representative in a medical device company. It has come to your attention that a blogger wrote a post that contains inaccurate information about your medical device. On the same day, you learn of a patient that has shared personal experiences with your device on a forum and misinformed other patients about the device’s use. You believe that the way that both these stories are represented may be harmful to the public health. You start typing away at your answer, informing the blogger and forum members of their mistakes. FDA guidance suggests that you should stop first and ask yourself: is it worth your while?

The FDA maintains that you have no obligation to correct any information published by a third party who is not under the firm’s control or influence. This is regardless of whether the firm owns or operates the platform on which the communication appears.

The FDA leaves this to the discretion of the pharma company or medical devices company. If the company chooses to engage in the correction of misinformation, it needs to adhere to certain approaches outlined in the guidance – for instance it cannot only correct negative misinformation written about the medical device while ignoring an overstatement of the benefits of the product.

Download complete draft FDA social media guidance on Correcting Independent Third-Party Misinformation about Prescription Drugs and Medical Devices.

Draft Guidance II: Internet/social media platforms with character space limitations

This FDA draft guidance is more comprehensive than the first and seems more complicated to execute. The guidance describes the FDA’s current thinking about how medical devices and drug manufacturers and marketers should present benefit and risk information of promotional materials in channels that have “character space limitations” (mainly Twitter, and “sponsored links” on search engines such as Google). The guidance does not include platforms such as Facebook and YouTube where there are no space limitations.

The main takeaway: Risk information must appear alongside risk information. Both must be presented in the same message. The FDA clearly states that having risk information on only a Twitter cover photo is insufficient and that main risk information should be included in the short message as well. If a medical company concludes that adequate benefit and risk information, as well as other required information, cannot all be communicated within the same character-space-limited communication, then the firm should reconsider using that platform for the intended promotional message. To many companies, this will be the case. To make matters more complicated, a link should be should be supplied that brings visitors to a page that is solely dedicated to risk information.

The guidance on how promotional materials should be prepared and presented goes on at length in its recommendation – using the example of a fictional drug they call NoFocus (And some people say that the FDA has no humor….).

The use of so many examples shows how complex this field is and the extent to which the FDA does not have a clear grasp of the way it should be managed.

Download complete draft FDA social media guidance on Internet/Social Media Platforms with Character Space Limitations— Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices


Via Plus91, Giuseppe Fattori
more...
No comment yet.
Rescooped by eMedToday from Digital marketing pharma
Scoop.it!

Digital resources – bridging the gap between HCP demand and pharma supply

Digital resources – bridging the gap between HCP demand and pharma supply | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
In the year (2014) that we reached the tipping point of medical professional ‘digital natives’, how well is the pharma industry keeping pace with HCP demand for digital resources?

Via Olivier Delannoy
more...
No comment yet.
Rescooped by eMedToday from Latest mHealth News
Scoop.it!

5 Ways to Engage Patients in Digital Health

5 Ways to Engage Patients in Digital Health | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Being the Marketing Director for KryptonWorx, a digital health company located between Cairo and Charleston, I was forced out of my fact-based physician mindset and into a right-brained designer mentality.

Via Sam Stern
more...
No comment yet.
Rescooped by eMedToday from Pharma Hub
Scoop.it!

Accenture Mobility Digital Trends 2014

Digital Trends Craig McNeil / Philippe Bonneton February 2014 Accenture Digital

Via Philippe Marchal/Pharma Hub
more...
Bettina Gifford's curator insight, July 3, 5:33 PM

Mobile communication campaigns  have to be  in budget...

Rescooped by eMedToday from 9- PHARMA MULTI-CHANNEL MARKETING by PHARMAGEEK
Scoop.it!

Interview : Social Media Use for Multi-Channel Pharma Marketing

Interview : Social Media Use for Multi-Channel Pharma Marketing | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

New social media technologies are opening up new channels of communication for pharma marketers to reach out to their healthcare stakeholders.  How can pharmas navigate the social responsibilities that come with social media use?

Wiley Interface asked Dr. Eiji Sasahara, Partner of the Healthcare Cloud Initiative, NPO how FDA guidance on social media use for multichannel marketing is impacting pharmas in Japan and the opportunities he envisions for social media use.

 

Wiley Interface : Can you share more with us about yourself and your experience in healthcare cloud?

Dr. Eiji Sasahara : At Healthcare Cloud Initiative, NPO, I’ve focused on impacts of the East Japan Earthquake and Tsunami towards Governance, Risk, and Compliance (GRC) management in healthcare IT.  Healthcare consumers are the key stakeholders in the total healthcare value chain, eagerly seeking information about health promotion, disease prevention, treatment of specific conditions, and management of various health conditions and chronic diseases.  After the earthquake, tsunami and nuclear accidents, the stakeholders have been adopting and utilizing social media, based on public cloud services, through both fixed and mobile broadband networks.  However, in Japan, most of healthcare providers and pharmaceutical companies do not have integrated gateway for social media communications.  Lack of a communication gateway targeting healthcare consumers online means gaps in stakeholder communications.  In addition, the number of healthcare consumers with a good understanding of the potential risks in social media, such as misinformation about drugs and medical devices, is still small.  As social media is a public communication tool and users need to understand their social responsibilities, it is essential to minimize the consumers’ risks by utilizing standardized social media technologies under integrated structure for social media management.

Wiley Interface : What are the key FDA guidance on social media use for multichannel marketing?  What does it encompass?

Dr. Eiji Sasahara : In the US, FDA has released four drafts that address various topics related to use of Social Media as follows:

i) Internet/Social Media Platforms with Character Space Limitations – Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices (June, 2014)
ii) Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices (June, 2014)
iii) Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics (January, 2014)
iv) Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices (December, 2011)

The most influential draft guidance is “Fulfilling Regulatory Requirements for Postmarketing Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics” in January 2014, because it referred to emerging digital marketing media mix, including Owned Media, Paid Media and Earned Media.

Wiley Interface : When was the FDA guidance on social media for multichannel marketing implemented in Japan?

Dr. Eiji Sasahara : In Japan, the Ministry of Health, Labour and Welfare (MHLW) started the official YouTube channel in February 2009 and responded to concerns over the spread of the H1N1 swine flu virus after April 2009, and also initiated an official Twitter account for immediate information sharing in September 2010. The goal of the MHLW has been to efficiently communicate critical information to the public, and create new channels of communication by leveraging on social media technologies.

However, with regard to promotion, labeling and off-label information for MHLW/PMDA-regulated drugs and medical devices, there is no official Social Media use guideline. Lack of standardized Social Media guidelines in Japan is challenging for interactive communications on regulated products between the regulators and healthcare consumers, and MHLW has a keen interest in what happens in the US.

Wiley Interface : What is the impact of FDA guidance on social media use for multichannel marketing by pharma companies in Japan?

Dr. Eiji Sasahara : It is the fact that common Social Media services and technologies are available to healthcare consumers in both the US and Japan.

Major Japan-oriented pharmaceutical companies depend on sales from the US market, and their head offices in Japan should be responsible for supervising Social Media management at global corporate level.

Most of non-Japanese pharmaceutical companies are going to utilize Social Media in total management life cycle of newly approved drugs in the US, and, sooner or later, those products will enter the Japan market. Sharing best practices of Social Media utilization is essential worldwide.

Wiley Interface : Does the FDA guidance on social media use for multichannel marketing make life easier for pharma companies in Japan or more challenging?

Dr. Eiji Sasahara : Social Media communications are utilized by a variety of stakeholders surrounding pharmaceutical companies, and cross-functional and real-time approaches will be required after implementation of FDA’s guidelines. Under current organizational and IT structure for corporate and product communications, it seems challenging.

Wiley Interface : How can pharma companies in Japan overcome the challenges of the FDA guidance on social media use for multichannel marketing in Japan?

Dr. Eiji Sasahara : Utilization of Social Media is the challenge in total pharmaceutical value chains, including R&D, manufacturing & distribution, sales & marketing, and medical affairs. In some cases, reform of organizational and IT structure will be required at corporate level.

Wiley Interface : Do you see any opportunity with the FDA guidance on social media use for multichannel marketing? If so, who will benefit from it?

Dr. Eiji Sasahara : Social Media will also provide opportunities to implement consumer-driven, digital-based and real-time multichannel marketing practices with pharmaceutical companies heavily dependent on traditional workforce and paper-based materials.

Healthcare consumers should benefit from it first, and their experience with satisfaction will generate both commercial and social values for pharmaceutical companies.

Wiley Interface : What are the trends that you envision in the next few years for healthcare cloud?

Dr. Eiji Sasahara : Maturity of Social Media utilization and expansion of mobile devices (including smartphone/tablet and wearable sensors) will lead to enhancement in Volume, Variety and Velocity (3Vs) of Big Data on the cloud.  To balance benefit and risk of Big Data on uncontrollable cloud computing environment, collaboration between social media managers and data scientists will be the key for consumer-driven innovation in the healthcare industry.



Via Plus91, Lionel Reichardt / le Pharmageek
more...
No comment yet.
Rescooped by eMedToday from Jaymin
Scoop.it!

Digital marketing solutions to enhance ROI of Pharma Companies

Digital marketing solutions to enhance ROI of Pharma Companies | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

 

Today, Most of the Pharmaceuticals marketing companies adopted digital marketing techniques much lately for expanding their brand awareness. These strategies bring unique opportunity as the pharma marketing company can experience a robust ROI.


Via jaymin aegis
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Change of mindset is key to innovation

Change of mindset is key to innovation | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
SPONSORED COMMENT: Change of mindset is key to innovation
PharmaTimes
Digital tools can help pharma to reduce its sales and marketing spend by broadening its reach, and enabling it to deliver tailored messages to target groups.
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Digital health startup rides funding wave - Crain's New York Business

Digital health startup rides funding wave - Crain's New York Business | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Digital health startup rides funding wave
Crain's New York Business
"With this funding, we will further develop our product portfolio to assist additional stakeholders in the pharmaceutical market," Truveris CEO said Bryan Birch said in a statement.
more...
No comment yet.
Rescooped by eMedToday from Digital-News on Scoop.it today
Scoop.it!

New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical

New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical ...
MarketWatch
RESTON, Va., July 10, 2014 /PRNewswire/ -- comScore, Inc.

Via Thomas Faltin
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

Patient insight essential for digital marketing

Patient insight essential for digital marketing | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
POST SUMMARY: It’s essential for pharma digital marketers to have and in depth understanding of patients including, why they chose our product, what barriers are needed to overcome to stay on therapy and how can we provide them with help and...
more...
No comment yet.
Rescooped by eMedToday from SoLoMo Health: eHealth, mHealth, Health & Social Media, Digital Health, Telehealth, Quantified Self, Wearable Tech
Scoop.it!

Pfizer Forms a Strategic Alliance with CliniWorks to Develop Population Health Management Platform

Pfizer Forms a Strategic Alliance with CliniWorks to Develop Population Health Management Platform | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

CliniWorks today announced a strategic alliance between and Pfizer Inc.to jointly advance the parties’ respective capabilities in working with healthcare provider organizations to identify and close clinical or quality gaps to improve population...


Via Emmanuel Capitaine , Celine Sportisse
more...
Rescooped by eMedToday from Latest mHealth News
Scoop.it!

10 Digital Health Trends Over The Next 20 Years

10 Digital Health Trends Over The Next 20 Years | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Earlier this week I participated in the world’s first online digital health conference, Digital Health Pulse, organized by digital health consultancy, Enspektos. Speaking at the ...

Via Sam Stern
more...
Rescooped by eMedToday from Hospitals: Trends in Branding and Marketing
Scoop.it!

Healthcare’s digital future | McKinsey & Company

Healthcare’s digital future | McKinsey & Company | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Insights from our international survey can help healthcare organizations plan their next moves in the journey toward full digitization. A McKinsey & Company article.

Via Richard Meyer, Art Jones, eMedToday
more...
Art Jones's curator insight, July 7, 7:59 PM

#TheFutureofHealthcare

Rescooped by eMedToday from #eHealthPromotion, #web2salute
Scoop.it!

Social media’s role in clinical research

Social media’s role in clinical research | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

Can social media really play a part in curing a disease?

During this year’s DIA Annual Meeting in San Diego, I found out the answer is “yes.”

From providing platforms for open discussion and raising awareness to patient recruitment, new uses for social media are being used to further clinical research.

Patients helping patients

Several of the presentations focused on social media use in clinical trials used statistics to show what we all know about social media – that people use it to come together to find people and information that relate to their experiences.

Brian Lowe from Inspire, who creates patient communities as platforms for access to highly engaged, authentic patient populations, explained how patients are using online communities to become informed, find support and be heard. They use their stories to inspire others to seek new forms of treatment and provide support and hope to those going through similar experiences.

Other presenters, like by Melissa Mottolo, patient recruitment strategy associate from Genentech, a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious or life-threatening medical conditions, provided data to support the message that patients are seeking platforms for support and information related to their diseases – a 2012 PwC social media consumer survey showed that 29 percent of respondents said they use social media to access information on other patients’ experiences with their disease.

Listening – the new patient recruitment tactic

In several presentations, social listening – a method of monitoring and analyzing social media by gathering data from a variety of sources (online communities, blogs, social networks, message boards and wikis) – was advocated for use during the development of patient recruitment and retention clinical trial plans. Social listening’s value is in identifying influencers at the patient level, identifying digital spaces at a country level and by identifying health care providers and sites.

Although social media use adoption is slow, the clinical research industry is beginning to recognize its use as a new tool in patient recruitment according to Ken Getz, director and associate professor CSDD, Tufts University School of Medicine. Getz reported use of social media for patient recruitment on 10 percent of clinical trials but said according to the Tufts research he was referencing, 75 percent of the U.S. respondents expect the use of social media for recruitment to grow.



Via Plus91, Giuseppe Fattori
more...
Andrea Robotti's curator insight, July 7, 4:24 AM

Riflessione che fa seguito a quella specifica che ho fatto ieri sull'uso di Twitter da parte dei medici.

In questo caso l'argomento sono i social media in generale e il contesto è quello della ricerca clinica, ma l'essenza del messaggio non cambia.

L'auspicio rimane, infatti, che si rafforzino e ampliino i segnali positivi sull'efficacia nell'uso di questi canali che sono già emersi.

Il reclutamento di pazienti e la condivisione delle proprie esperienze di terapia da aprte degli stessi sono gli esempi più noti, ma si spera di poter fare meglio e che le aziende di settore si impegnino maggiormente per diffondere questa abitudine. 

Scooped by eMedToday
Scoop.it!

Mobile apps and pharma: health in your pocket

Mobile apps and pharma: health in your pocket | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Little blog I wrote today on #mHealth - Mobile apps and pharma: health in your pocket #hcsmeu #hcsm #pharma http://t.co/KMUg0xOQqW
more...
No comment yet.
Rescooped by eMedToday from SoLoMo Health: eHealth, mHealth, Health & Social Media, Digital Health, Telehealth, Quantified Self, Wearable Tech
Scoop.it!

Health innovation: When big ideas meet big pharma

Health innovation: When big ideas meet big pharma | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

After attending OPEN Health's inaugural 'Health Innovation: Big Ideas' event in London, Paul Tunnah outlines some of the concepts that could be game changers for the pharma industry and the broader future of healthcare. 


Via Alex Butler, Celine Sportisse
more...
Rowan Norrie's curator insight, July 7, 3:34 AM

Cosnider this - "Today's 10-year olds could be the first generation to have a lower life expectancy than their parents."

Rescooped by eMedToday from SoLoMo Health: eHealth, mHealth, Health & Social Media, Digital Health, Telehealth, Quantified Self, Wearable Tech
Scoop.it!

Survey Says: 75% of consumers expect drug companies to provide additional services that complement their medical products

Survey Says: 75% of consumers expect drug companies to provide additional services that complement their medical products | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

Via Ash Rishi, Celine Sportisse
more...
No comment yet.
Rescooped by eMedToday from 4- PATIENT EMPOWERMENT & E-PATIENT by PHARMAGEEK
Scoop.it!

Patients Want Digital from Pharma | PM360

Patients Want Digital from Pharma | PM360 | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it

Patients Want Digital from Pharma
by Sam Welch on June 9th, 2014


 

New survey data released by Accenture found that more than 75% of consumers expect drug companies to provide additional services that complement their medical products.

Digital platforms are frequently mentioned as the preferred method of contact. Sixty-nine percent of respondents said they’d prefer information from pharma companies via email, followed by printed materials (66%), websites (48%), mobile apps (44%) and social media (38%). Print media made the list, though patients have made it clear that they are seeking resources through digital channels.

Of interest to marketers, the data show that 64% of patients are willing to trade personal information to get free, relevant content. Not only should we engage around this opportunity, this indicates that marketers can achieve access to more customer data in order to personalize information to each patient’s needs. And digital expands opportunities to track outcomes and tailor content to the individual.

Consumers want more tools to manage their healthcare. If we’re really moving into an age where “an app a day can keep the doctor away,” then we must address this need to make valuable tools available to patients.

Read the full Accenture report here.



Via Laurent FLOURET, dbtmobile, Lionel Reichardt / le Pharmageek
more...
Laurent FLOURET's curator insight, July 2, 6:30 AM

At this stage, it is beyond the wake up call...

Bettina Gifford's curator insight, July 2, 6:55 PM
Are you meeting patient needs with digital support?
Rescooped by eMedToday from Digital Marketing for Pharma
Scoop.it!

There's Now An 'Instagram For Doctors'

There's Now An 'Instagram For Doctors' | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
Now they can actually visualize different diseases and abnormalities.

Via Julie O'Donnell
more...
No comment yet.
Scooped by eMedToday
Scoop.it!

The Evolving Landscape Of Medical Apps

The Evolving Landscape Of Medical Apps | Pharma: Trends and Uses Of Mobile Apps and Digital Marketing | Scoop.it
The Evolving Landscape Of Medical Apps Health IT Outcomes (press release) As pharmaceutical companies begin to offer cutting edge healthcare services, a report by HIT Consultant with graphs from Pocket.MD has added color to the biggest mobile...
more...
No comment yet.